Search results
MannKind's (NASDAQ:MNKD) investors will be pleased with their stellar 268% return over the last...
Simply Wall St. via Yahoo Finance· 2 years agoThe most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if...
Investors in MannKind (NASDAQ:MNKD) have seen solid returns of 115% over the past five years
Simply Wall St. via Yahoo Finance· 6 months agoIt hasn't been the best quarter for MannKind Corporation (NASDAQ:MNKD) shareholders, since the share...
Why MannKind Stock Soared 19% Higher on Tuesday
Motley Fool· 10 months agoCommercial-stage biotech MannKind (NASDAQ: MNKD) was a top choice of investors on the second day of the trading week. Tuesday saw MannKind's share price...
United Therapeutics (UTHR) Q3 Earnings & Sales Beat Estimates
Zacks via Yahoo Finance· 2 years agoUnited Therapeutics UTHR reported third-quarter 2022 adjusted earnings of $4.91 per share, which...
What's in Store for United Therapeutics' (UTHR) Q2 Earnings?
Zacks via Yahoo Finance· 2 years agoUnited Therapeutics' (UTHR) investor focus is likely to have been on sales figures of Tyvaso,...
United Therapeutics (UTHR) Q2 Earnings Miss Estimates, Revenues Up
Zacks via Yahoo Finance· 2 years agoUnited Therapeutics' (UTHR) second-quarter earnings missed estimates, while sales beat the same....
United Therapeutics (UTHR) Q1 Earnings Beat, Sales Miss
Zacks via Yahoo Finance· 1 year agoUnited Therapeutics' (UTHR) first-quarter 2023 earnings beat estimates while sales miss the same....